Altimeter Capital
Technology-focused investment firm founded by Brad Gerstner, managing both public and private capital. Known for growth-stage investments in transformative technology companies and SPAC transactions including the 23andMe merger.
Location
Menlo Park, USA
Founded
2008
AUM
$15B+
Investment Range
$50M - $500M
Portfolio Companies
2
Focus
generalist
Fund Stages
series-c, growth
Investment Thesis
Altimeter Capital invests in transformative technology companies at growth stage, with expertise in both public and private markets. In healthcare, they focus on technology-enabled healthcare companies that can achieve significant scale and market impact. They are known for taking concentrated positions in high-conviction investments.
Team
Partners / Managing Directors (Health & Bio Focus)
- Brad Gerstner - Founder & CEO
- Jamin Ball - Partner
Other Key Team Members
- Ram Parameswaran - Partner
Focus Areas
- Healthcare Technology
- Consumer Health
- Digital Health
- Life Sciences
- Technology
- SaaS
- Fintech
Notable Exits
- 23andMe - SPAC Merger (2021, merged with VG Acquisition Corp)
- Snowflake - IPO (2020, NYSE: SNOW)
- Unity Technologies - IPO (2020, NYSE: U)